	现金及等价物		日
AbbVie	USD 5.23B	400M	2025-12
Amgen	USD 12.04B	2.91B	2026-03
Anika Therapeutics	USD 41.02M	16.46M	2026-03
Arrowhead Research	USD 201.64M	112.94M	2025-12
AstraZeneca	USD 7.56B	1.85B	2026-03
BioCryst Pharmaceuticals	USD 335.91M	251.83M	2025-12
Biogen	USD 3.38B	374.2M	2026-03
Bristol-Myers Squibb	USD 9.57B	635M	2026-03
Enanta Pharmaceuticals	USD 37.44M	5.14M	2025-12
Gilead Sciences	USD 7.56B	234M	2025-12
GlaxoSmithKline	GBP 3.44B	292M	2026-03
Halozyme Therapeutics	USD 133.82M	285.84M	2025-12
Heron Therapeutics	USD 43.07M	26.55M	2025-09
Immunic	USD 15.48M	19.65M	2025-12
Incyte	USD 4.02B	435.22M	2026-03
Insmed	USD 510.44M	175.68M	2025-12
Ionis Pharmaceuticals	USD 1.92B	758M	2026-03
J&J	USD 21.69B	1.98B	2026-03
Karyopharm Therapeutics	USD 60.54M	22.87M	2025-12
Ligand Pharmaceuticals	USD 174.93M	489.59M	2025-12
Merck	USD 5.33B	9.24B	2026-03
Neurocrine Biosciences	USD 266.5M	446.5M	2026-03
Novartis	USD 6.88B	4.56B	2026-03
Novavax	USD 240.63M	27.39M	2025-12
Pfizer	USD 1.7B	561M	2026-03
PTC Therapeutics	USD 984.65M	312.03M	2025-12
Roche Holding	CHF 7.55B	579M	2025-06
Sarepta Therapeutics	USD 801.28M	188.2M	2025-12
Vertex Pharmaceuticals	USD 7.25B	638.6M	2026-03